Academic staff at Faculty of Medicine in Pilsen, Central Library of Charles University
Publications
- The clinical, histopathological and imaging methods characteristics of Non-Hodgkin lymphomas in patients with brain involvement2013 | Faculty of Medicine in Pilsen
- The incidence of malignancies and surveillance of hematopoietic stem cells donors--the results of the Haemato-Oncology Department University Hospital in Plzen (Pilsen) and Czech National Marrow Donors Registry observation2012 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Angioimmunoblastic T-cell Lymphoma as a Very Poor-Prognosis Malignancy – a Single Centre Experience2012 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Treatment of patients with relapsed/refractory Hodgkin lymphoma2011 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Primary cutaneous histiocyte and neutrophil-rich CD30+ and CD56+ anaplastic large-cell lymphoma. A rare case report ad review of related literature2007 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Primary cutaneous histiocyte and neutrophil-rich CD30+ and CD56+ anaplastic large-cell lymphoma. A rare case report ad review of related literature2007 | Central Library of Charles University
- Primary cutaneous hisiocyte and neutrophilo-rich CD30+ and CD56+ anaplastic large-cell lymphoma with prominent angioinvasion and nerve involvement in the forehead and scalp of an immunocompetent woman2006 | Central Library of Charles University
- Testicular lymphomas2004 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study2024 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors2024 | Faculty of Medicine in Pilsen, Central Library of Charles University, Faculty of Medicine in Hradec Králové
Loading network view...
